Jacobs Levy Equity Management
RPRX

Jacobs Levy Equity Management’s Repros Therapeutics Inc. RPRX Stock Holding History

Jacobs Levy Equity Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-114,165
Closed -$137K – 1103
2017
Q1 		$137K Sell
114,165
-153,965
-57% -$192K ﹤0.01% 834
2016
Q4 		$354K Hold
268,130
– – 0.01% 735
2016
Q3 		$560K Sell
268,130
-46,900
-15% -$92.8K 0.01% 697
2016
Q2 		$507K Sell
315,030
-8,399
-3% -$16.1K 0.01% 753
2016
Q1 		$314K Buy
+323,429
New +$316K 0.01% 859

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return